2008 Annual Report and Notice

RNS Number : 0906Q

Hutchison China Meditech Limited

06 April 2009

 



Hutchison China MediTech Limited ('Chi-Med')

(AIM: HCM)

2008 Annual Report and

Notice of Annual General Meeting

London: Monday, 6 April 2009: Chi-Med today announces that its 2008 Annual Report  together with the Notice of Annual General Meeting and the Proxy Form have been posted to shareholders. The documents can be accessed from the website of Chi-Med (www.chi-med.com).

Ends

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson   Anthony Carlisle   David Dible	Telephone: [phone] [phone] [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients. 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

MSCGIGDSGDGGGCX